VOPP1: A Potential Drug Target and Biomarker (G81552)

Target Name: VOPP1

NCBI ID: G81552

VOPP1

VOPP1: A Potential Drug Target and Biomarker

Hypothetical protein DKFZp564K0822, also known as VOPP1, has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function have made it an attractive target for researchers to investigate.

VOPP1 is a protein that is expressed in various tissues, including the brain, heart, and kidneys. Its primary function is to regulate the movement of ions and molecules across cell membranes. It does this by playing a role in the regulation of the voltage-dependent ion channels, which are responsible for the movement of charged particles into and out of cells.

One of the unique features of VOPP1 is its ability to form a homotetrameric dimer, which means that it can form a pair with another VOPP1 protein and form a monomer. Thisdimerization is important for the protein's functional activity, as it allows for the formation of a stable channel that can be used to transport ions across cell membranes.

Research has shown that VOPP1 is involved in a number of important physiological processes in the body, including the regulation of ion and water transport, as well as the regulation of pain and inflammation. It is also involved in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the potential benefits of targeting VOPP1 is its potential to treat a wide range of diseases. Its involvement in the regulation of ion and water transport makes it a potential target for drugs that can modulate these processes. It is also involved in the regulation of pain and inflammation, which makes it a potential target for drugs that can alleviate these symptoms.

In addition to its potential as a drug target, VOPP1 has also been identified as a potential biomarker for a number of diseases. Its involvement in the regulation of ion and water transport makes it a potential target for diagnostic tests that can measure changes in these processes. It is also involved in the regulation of pain and inflammation, which makes it a potential target for diagnostic tests that can measure changes in these processes.

Research has shown that VOPP1 is involved in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its involvement in these diseases makes it a potential candidate for targeting with drugs or other therapeutic agents.

In conclusion, VOPP1 is a protein that has the potential to be a drug target and biomarker for a wide range of diseases. Its unique structure and function make it an attractive target for researchers to investigate, and its involvement in the regulation of ion and water transport, as well as pain and inflammation, make it a potential candidate for targeting with drugs or other therapeutic agents. Further research is needed to fully understand its role and potential as a drug target and biomarker.

Protein Name: VOPP1 WW Domain Binding Protein

Functions: Increases the transcriptional activity of NFKB1 by facilitating its nuclear translocation, DNA-binding and associated apoptotic response, when overexpressed

The "VOPP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VOPP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets